ambossIconambossIcon

Principles of pain management

Last updated: March 18, 2026

Summarytoggle arrow icon

Pain is a distressing sensory and emotional experience linked to, or resembling that linked to, current or potential tissue injury. Pain is classified by duration (i.e., acute, subacute, or chronic) or type (i.e., nociceptive, neuropathic, or nociplastic). Clinical evaluation of pain involves a thorough history and physical examination and assessment of pain severity using a standardized pain intensity scale. Pain management is multimodal and includes analgesics, nonpharmacological analgesia, and/or interventional pain management strategies. The WHO analgesic ladder can help clinicians select an appropriate pain management strategy based on pain severity and response to existing management. Complications of pain management vary based on the agent and should be balanced against symptom relief. Adverse effects of NSAIDs include cardiovascular complications, gastritis, and kidney impairment. Adverse effects of opioid therapy include respiratory depression, nausea, and altered mental status.

This article focuses on the principles of pain management. Acute pain management, chronic noncancer pain management, and pain management in palliative care are detailed separately.

Classification of paintoggle arrow icon

By duration

  • Acute pain
    • A warning signal indicating actual or potential tissue damage that triggers a protective reaction
    • Typically associated with trauma, surgery, and/or acute illness
    • Lasts < 1 month [1]
  • Subacute pain: lasts 1–3 months [1]
  • Chronic pain
    • Pain that lasts beyond the normal tissue healing time (> 3 months) [1][2]
    • Unlike acute pain, chronic pain has no protective role in preventing further tissue damage and can be considered a disease entity in its own right.

By type [3]

Pain is a distressing sensory and emotional experience linked to, or resembling that linked to, current or potential tissue injury.

Pathophysiologytoggle arrow icon

Pain pathway

Dimensions of pain

Pain is a complex phenomenon characterized by multiple subjective dimensions as well as the objective physiological and behavioral responses it elicits.

  • Sensory-discriminative dimension: the physical attributes of pain (e.g., quality, localization, intensity, duration)
  • Affective-motivational dimension: the emotional aspect of pain, representing the associated unpleasantness, distress, and drive to escape or avoid the stimulus
  • Cognitive-evaluative dimension: the mental interpretation and modulation of pain based on attention, memory, beliefs, expectations, and/or context
  • Behavioral dimension: the observable and physiological expressions of pain

The biopsychosocial model of pain proposes that pain arises from a dynamic interaction between biological factors (e.g., tissue injury, genetics), psychological factors (e.g., pain-related beliefs, coping mechanisms, catastrophizing), and social factors (e.g., social support system, work). Together, these factors shape the perceived intensity and impact of pain. In chronic pain, the psychological and social components often amplify and sustain the experience, frequently contributing to distress and disability significantly more than the original physical injury itself.

Subtypes and variantstoggle arrow icon

Radiating pain

Referred pain

Overview of referred pain
Organ Dermatome Projection
Diaphragm C4 Shoulders
Heart T3–4 Left chest
Esophagus T4–5 Retrosternal
Stomach T6–9 Epigastrium
Liver, gallbladder T10–L1 Right upper quadrant
Small bowel T10–L1 Periumbilical
Colon T11–L1 Lower abdomen
Bladder T11–L1 Suprapubic
Kidneys, testicles T10–L1 Groin

References:[6][7]

Phantom limb syndrome

References:[9]

Evaluation of paintoggle arrow icon

To optimize pain management, a thorough history and assessment of pain is required prior to initiating treatment.

  • Pain characteristics (location, quality, temporal aspects, triggers)
  • Associated symptoms (changes in mobility and strength)
  • Previous pain assessments and/or treatment
  • Pain intensity scale: subjective grading of pain severity by the patient
  • Impact of pain
  • Pain diary: regular documentation of the pain intensity to identify peaks and triggers; enables treatment optimization

Pain can be difficult to assess in nonverbal patients; obtain supporting information from caretakers and use a specialized pain score, e.g., the nonverbal pain scale.

Be aware of implicit bias in the assessment of pain: Hispanic and Black patients are less likely to receive any and/or appropriate analgesia compared to White patients, even when reported pain scores are identical. [10][11]

Pain is subjective! Pain scales are used to assess a patient's pain and response to pain management over time. They cannot be used to compare pain intensity between patients.

References:[12]

Analgesicstoggle arrow icon

WHO analgesic ladder

The WHO analgesic ladder is a 3-step algorithm for the management of acute and chronic pain.

  • Regular analgesic (modified-release drugs, administered at fixed times and doses)
    • By the mouth: preferably, analgesics should be given orally.
    • By the clock: regular administration at fixed times, rather than on demand
    • By the ladder (symptom-oriented): if the patient is still in pain, it is necessary to go up a step
  • Appropriate PRN medication
    • Short-acting analgesics for peaks in pain
    • If PRN medication is required ≥ 3×/day → inadequate analgesia likely; review the regular medication
  • Additionally, concurrent treatment with adjuvant drugs
Management of pain using WHO analgesic ladder [13]
Pain severity Non-opioid analgesics Mild opioids Strong opioids Adjuvant drugs
Step I Mild Include Avoid Avoid If required
Step II Moderate Include Consider Avoid If required
Step III Severe Include Consider Consider If required

Non-opioid analgesics are first-line agents for pain; prescribe them alone for mild to moderate pain and in combination with opioids for severe pain. [14]

For both opioid and non-opioid analgesics, use the minimal effective dose for the shortest duration of time to minimize adverse effects. Pain intensity scales should be used in regular intervals to assess the success of pain management.

Oral analgesics

The following information pertains to adults. See "Pain management in children" for pediatric recommendations.

Drug class Drug Important considerations
Oral analgesics
Non-opioids Acetaminophen
NSAIDs
Selective COX-2 inhibitor
Sodium channel blocker
  • Suzetrigine
  • For moderate to severe acute pain
  • First dose on an empty stomach; subsequent doses can be taken with food
  • Avoid use in patients with severe hepatic impairment (Child class C).
Opioids
Combination analgesics

All patients being discharged with opioid medications should receive counseling on the use of prescription opioids.

Parenteral analgesics

Parenteral analgesics
Drug class Drug Important considerations
NSAIDs
Opioids
  • See "Opioids" for further information.

Analgesic suppositories

Topical analgesics

Topical analgesics
Drug Dose Indications
Lidocaine
Diclofenac

Adjuvant analgesics

Anticonvulsants

Anticonvulsants are useful adjuncts in the management of neuropathic pain. They typically will not be helpful for acute pain, rather are more commonly used for chronic neuropathic pain.

Muscle relaxants

Consider muscle relaxants in patients with pain associated with muscle spasticity.

Antidepressants

Tricyclic antidepressants and SNRIs can be helpful for chronic pain syndromes and neuropathic pain. Antidepressants for chronic or neuropathic pain are recommended by the American Society of Anesthesiologists in their 2010 guideline, but only duloxetine is FDA-approved for this indication. All others are off-label use. [23][24]

Complications of pain medicationtoggle arrow icon

The complications listed here are not exhaustive. For further information on adverse drug effects, see also "Drug hypersensitivity reactions."

Complications of non-opioid pain management [14]

See also "Nonsteroidal anti-inflammatory drugs," "Selective COX-2 inhibitors," and "Other non-opioid analgesics."

Complications of non-opioid pain management
‎Medication Complication Clinical manifestations Prevention and management
Acetaminophen
NSAIDs and selective COX-2 inhibitors
  • Cardiovascular complications
  • Gastrointestinal complications
  • Avoid in patients with bleeding disorders.
  • Avoid if feasible in the perioperative period.
  • Serious skin reactions (rare)

Complications of opioid therapy [14][28]

See also "Adverse effects of opioids."

Complications of opioid therapy
Complication Prevention and management
Respiratory complications (e.g., opioid-induced respiratory depression) [1][28]
Nausea and vomiting [28]
Opioid-induced constipation [28]
Urinary retention [29]
  • Discontinue or reduce the opioid and/or change the route of administration.
Mental status changes (e.g., delirium, altered mental status, hallucinations) [28]
Myoclonus [28]
Neuroendocrine complications (e.g., hypogonadism, hypocortisolism, hyperprolactinemia) [30]
Pruritus [28]
Opioid use disorder (OUD) [1]
Opioid overdose [1]

Some adverse effects of opioid therapy (e.g., delirium, pruritus) can be minimized with dose reduction, using a different route of administration, or by switching to a different agent. [29]

Opioid therapy requires balancing symptom relief against complications. Educate patients about adverse effects, and make proactive plans for complication management. [29]

Nonpharmacological analgesiatoggle arrow icon

Multiple nonpharmacological therapies are often used in combination (e.g., exercise therapy and cognitive behavioral therapy).

Physical modalities [1][31]

Consider referral to physical therapy and/or occupational therapy.

Patients may require analgesia to participate in physical therapy; maximize nonopioid pharmacological therapy first. [35][36]

Psychological modalities [1][31]

Refer to a psychologist as needed.

Other modalities [1][31]

Special patient groupstoggle arrow icon

Pain management in children [40][41]

Outpatient pain management

Aspirin is not recommended in most pediatric patients due to the risk of Reye syndrome. [42]

Procedural pain in neonates and infants

Related One-Minute Telegramtoggle arrow icon

Interested in the newest medical research, distilled down to just one minute? Sign up for the One-Minute Telegram in “Tips and links” below.

Referencestoggle arrow icon

  1. Dowell et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR. Recommendations and Reports. 2022; 71 (3): p.1-95.doi: 10.15585/mmwr.rr7103a1 . | Open in Read by QxMD
  2. Pain Management Best Practices Inter-Agency Task Force Report. https://www.hhs.gov/sites/default/files/pmtf-final-report-2019-05-23.pdf. Updated: May 9, 2019. Accessed: July 31, 2023.
  3. Todd N, McDannold N, Borsook D. Targeted manipulation of pain neural networks: The potential of focused ultrasound for treatment of chronic pain. Neurosci Biobehav Rev. 2020; 115: p.238-250.doi: 10.1016/j.neubiorev.2020.06.007 . | Open in Read by QxMD
  4. Harden RN, McCabe CS, Goebel A, et al. Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th Edition. Pain Medicine. 2022; 23 (Supplement_1): p.S1-S53.doi: 10.1093/pm/pnac046 . | Open in Read by QxMD
  5. Hayden JA, Et al.. Exercise therapy for chronic low back pain. Cochrane Database of Systematic Reviews. 2021; 2021 (10).doi: 10.1002/14651858.cd009790.pub2 . | Open in Read by QxMD
  6. Hegmann KT, et al. ACOEM Practice Guidelines: Opioids for Treatment of Acute, Subacute, Chronic, and Postoperative Pain. Occup Environ Med. 2014; 56 (12): p.e143-e159.doi: 10.1097/jom.0000000000000352 . | Open in Read by QxMD
  7. Center for Substance Abuse Treatment. Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders. Center for Substance Abuse Treatment. 2012.
  8. Thompson T, Terhune DB, Oram C, et al. The effectiveness of hypnosis for pain relief: A systematic review and meta-analysis of 85 controlled experimental trials. Neuroscience & Biobehavioral Reviews. 2019; 99: p.298-310.doi: 10.1016/j.neubiorev.2019.02.013 . | Open in Read by QxMD
  9. Driscoll MA, Edwards RR, Becker WC, et al. Psychological Interventions for the Treatment of Chronic Pain in Adults. PSPI. 2021; 22 (2): p.52-95.doi: 10.1177/15291006211008157 . | Open in Read by QxMD
  10. Vickers AJ, Vertosick EA, Lewith G, et al. Acupuncture for Chronic Pain: Update of an Individual Patient Data Meta-Analysis. J Pain. 2018; 19 (5): p.455-474.doi: 10.1016/j.jpain.2017.11.005 . | Open in Read by QxMD
  11. Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019; 160 (1): p.19-27.doi: 10.1097/j.pain.0000000000001384 . | Open in Read by QxMD
  12. IASP Terminology. https://web.archive.org/web/20260109164151/https://www.iasp-pain.org/resources/terminology/?ItemNumber=1698#Pain. Updated: December 14, 2017. Accessed: February 20, 2017.
  13. Chen S, Zhang J. Progress in Sympathetically Mediated Pathological Pain. J Anesth Perioper Med. 2015; 2 (4): p.216-225.doi: 10.24015/japm.2015.0029 . | Open in Read by QxMD
  14. Fitzcharles M, Cohen S, Clauw D, Littlejohn G, Usui C, Häuser W. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021; 397 (10289): p.2098-2110.doi: 10.1016/s0140-6736(21)00392-5 . | Open in Read by QxMD
  15. Hoffman KM, Trawalter S, Axt JR, Oliver MN. Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites.. Proc Natl Acad Sci U S A. 2016; 113 (16): p.4296-301.doi: 10.1073/pnas.1516047113 . | Open in Read by QxMD
  16. Lee P, Le Saux M, Siegel R, et al. Racial and ethnic disparities in the management of acute pain in US emergency departments: Meta-analysis and systematic review. Am J Emerg Med. 2019; 37 (9): p.1770-1777.doi: 10.1016/j.ajem.2019.06.014 . | Open in Read by QxMD
  17. Rosenquist EW. Evaluation of chronic pain in adults. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/evaluation-of-chronic-pain-in-adults?source=search_result&search=PRN%20medication&selectedTitle=2~150. Last updated: June 13, 2016. Accessed: February 20, 2017.
  18. Kufe DW, Pollock RE, Weichselbaum RR. Holland-Frei Cancer Medicine 6th edition. Hanley & Belfus Inc ; 2004
  19. Blondell RD, Azadfard M, Wisniewski A. Pharmacologic therapy for acute pain. Am Fam Physician. 2013; 87 (11): p.766-72.
  20. Blondell R, Azadfard M, Wisniewski A. Pharmacologic Therapy for Acute Pain. Am Fam Physician. 2013.
  21. VA/DoD Clinical Practice Guideline for the Use of Opioids in the Management of Chronic Pain. https://web.archive.org/web/20230727201832/https://www.healthquality.va.gov/guidelines/Pain/cot/VADoDOpioidsCPG.pdf. Updated: May 1, 2022. Accessed: June 19, 2023.
  22. Masudi T, Capitelli-McMahon H, Anwar S. Acute pain management in symptomatic cholelithiasis. World Journal of Gastrointestinal Surgery. 2016; 8 (10): p.713.doi: 10.4240/wjgs.v8.i10.713 . | Open in Read by QxMD
  23. Barr J, Fraser GL, Puntillo K, et al. Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit. Crit Care Med. 2013; 41 (1): p.263-306.doi: 10.1097/ccm.0b013e3182783b72 . | Open in Read by QxMD
  24. Khanna IK, Pillarisetti S. Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain.. Journal of pain research. 2015; 8: p.859-70.doi: 10.2147/JPR.S85951 . | Open in Read by QxMD
  25. European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones.. J Hepatol. 2016; 65 (1): p.146-181.doi: 10.1016/j.jhep.2016.03.005 . | Open in Read by QxMD
  26. McCarberg BH, Argoff CE. Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury. Int J Clin Pract. 2010; 64 (11): p.1546-1553.doi: 10.1111/j.1742-1241.2010.02474.x . | Open in Read by QxMD
  27. Anitescu M, Benzon HT et al.. Advances in topical analgesics. Curr Opin Anaesthesiol. 2013; 26 (5): p.555-561.doi: 10.1097/01.aco.0000432514.00446.22 . | Open in Read by QxMD
  28. Rosenquist RW et al. Practice Guidelines for Chronic Pain Management. Anesthesiology. 2010; 112 (4): p.810-833.doi: 10.1097/aln.0b013e3181c43103 . | Open in Read by QxMD
  29. Dharmshaktu P et al. Efficacy of Antidepressants as Analgesics: A Review. J Clin Pharmacol. 2012; 52 (1): p.6-17.doi: 10.1177/0091270010394852 . | Open in Read by QxMD
  30. Moore RA et al. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015.doi: 10.1002/14651858.cd008242.pub3 . | Open in Read by QxMD
  31. Kasper DL, Fauci AS, Hauser SL, et al. Harrison's Principles of Internal Medicine. McGraw-Hill Education ; 2015
  32. Felten DL, O'Banion MK, Maida ME. Netter's Atlas of Neuroscience. Elsevier Health Sciences ; 2015
  33. MacIver K, Lloyd DM, Kelly S, Roberts N, Nurmikko T. Phantom limb pain, cortical reorganization and the therapeutic effect of mental imagery. Brain. 2008; 131 (8): p.2181-2191.doi: 10.1093/brain/awn124 . | Open in Read by QxMD
  34. Subedi B, Grossberg GT. Phantom limb pain: Mechanisms and treatment approaches. Pain Res Treat. 2011; 2011: p.1-8.doi: 10.1155/2011/864605 . | Open in Read by QxMD
  35. Kang DO, An H, Park GU, et al. Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction. J Am Coll Cardiol. 2020; 76 (5): p.518-529.doi: 10.1016/j.jacc.2020.06.017 . | Open in Read by QxMD
  36. Rushfeldt CF, Sveinbjørnsson B, Søreide K, Vonen B. Risk of anastomotic leakage with use of NSAIDs after gastrointestinal surgery. Int J Colorectal Dis. 2011; 26 (12): p.1501-1509.doi: 10.1007/s00384-011-1285-6 . | Open in Read by QxMD
  37. McNicol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 2003; 4 (5): p.231-256.doi: 10.1016/s1526-5900(03)00556-x . | Open in Read by QxMD
  38. Rogers E, Mehta S, Shengelia R, Reid MC. Four Strategies for Managing Opioid-Induced Side Effects in Older Adults. Clin Geriatr. 2013; 21 (4).
  39. Fountas A, Chai ST, Kourkouti C, Karavitaki N. MECHANISMS OF ENDOCRINOLOGY: Endocrinology of opioids. European Journal of Endocrinology. 2018; 179 (4): p.R183-R196.doi: 10.1530/eje-18-0270 . | Open in Read by QxMD
  40. Hadland SE, Agarwal R, Raman SR, et al. Opioid Prescribing for Acute Pain Management in Children and Adolescents in Outpatient Settings: Clinical Practice Guideline. Pediatrics. 2024; 154 (5).doi: 10.1542/peds.2024-068752 . | Open in Read by QxMD
  41. American Academy of Pediatrics. Textbook of Pediatric Care. American Academy of Pediatrics ; 2016
  42. Krauss BS, Calligaris L, Green SM, Barbi E. Current concepts in management of pain in children in the emergency department. The Lancet. 2016; 387 (10013): p.83-92.doi: 10.1016/s0140-6736(14)61686-x . | Open in Read by QxMD
  43. Shenoi RP, Timm N, et al. Drugs Used to Treat Pediatric Emergencies. Pediatrics. 2020; 145 (1).doi: 10.1542/peds.2019-3450 . | Open in Read by QxMD
  44. Kelley-Quon LI, Kirkpatrick MG, Ricca RL, et al. Guidelines for Opioid Prescribing in Children and Adolescents After Surgery. JAMA Surg. 2021; 156 (1): p.76.doi: 10.1001/jamasurg.2020.5045 . | Open in Read by QxMD
  45. Keels E, Sethna N, et al. Prevention and Management of Procedural Pain in the Neonate: An Update (reaffirmed 2020). Pediatrics. 2016; 137 (2).doi: 10.1542/peds.2015-4271 . | Open in Read by QxMD
  46. Wilson-Smith E. Procedural Pain Management in Neonates, Infants and Children. Reviews in Pain. 2011.
  47. Rosen DA, Broadman LM. Ring Block of the Penis: A Proven Addition to Multimodal Pain Relief for Newborn Circumcision. Pediatrics. 2017; 140 (6).doi: 10.1542/peds.2017-2678 . | Open in Read by QxMD
  48. American Pain Society, Task Force on Pain in Infants, Children, and Adolescents;Committee on Psychosocial Aspects of Child and Family Health. The Assessment and Management of Acute Pain in Infants, Children, and Adolescents. Pediatrics. 2001.doi: 10.1542/peds.108.3.793 . | Open in Read by QxMD
  49. WHO's cancer pain ladder for adults. http://www.who.int/cancer/palliative/painladder/en/. Updated: February 20, 2017. Accessed: February 20, 2017.
  50. Latremoliere A, Woolf CJ. Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity. The Journal of Pain. 2009; 10 (9): p.895-926.doi: 10.1016/j.jpain.2009.06.012 . | Open in Read by QxMD
  51. Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. The Lancet Neurology. 2014; 13 (9): p.924-935.doi: 10.1016/s1474-4422(14)70102-4 . | Open in Read by QxMD
  52. Yam M: Loh YC. General Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation. International Journal of Molecular Science. 2018.
Sign up and get unlimited access.
disclaimer Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer